-
Science and Therapeutics Division and is a member of the Immunotherapy Integrated Research Center (IIRC). Their primary focus is on developing unique and first-in-class therapeutic drugs for cancer
-
with pursuing the major scientific research goals of Dr. Thomas's lab with a focus on studying the development of memory to vaccines and infections in infants. In this light, the Position's specific job
-
ineffective antigen targets and develop in vitro and in vivo models to test features of diverse immune specificities. Participate and engage in institutional, division, and the lab's principal investigator's
-
Zheng, and other collaborators to develop statistical and machine learning methods for medical decision-making in cancer prevention and early detection. Key areas of focus include, but are not limited
-
to advancing cancer research and developing new treatments. Our research integrates functional and clinical genomics to uncover molecular mechanisms driving cancer treatment resistance and accelerate
-
underlying cancer treatment resistance and the development of new therapeutics. The training will be mentored by Dr. Michael Haffner and members of his research group. Training opportunities are provided
-
underlying cancer treatment resistance and the development of new therapeutics. The training will be mentored by Dr. Peter Nelson and members of his research group. Training opportunities are provided through